Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
Tetanus and diphtheria toxoids and acellular pertussis vaccine?
|
Tdap
|
|
Types of Tdap?
|
Boostrix and Adacel
|
|
Minimum age for Boostrix ?
|
10 years
|
|
Minimum age for Adacel?
|
11 yrs
|
|
Administer Tdap at age 11 or 12 years for?
|
those who have completed the recommended childhood DTP/DTaP vaccination series and have not received a tetanus and diphtheria toxoid (Td) booster dose.
|
|
Persons aged ___ through ___ years who have not received Tdap should receive a dose?
|
Persons aged 13 through 18 years who have not received Tdap should receive a dose.
|
|
A ___ year interval from the last Td dose is encouraged when Tdap is used as a booster dose
|
however, a shorter interval may be used if pertussis immunity is needed?
|
|
HPV?
|
Human papillomavirus vaccine
|
|
Minimum age for HPV?
|
9 years
|
|
HPV4?
|
a quadrivalent vaccine, for the prevention of cervical, vaginal and vulvar cancers (in females) and genital warts (in females and males)
|
|
HPV2?
|
and a bivalent vaccine for the prevention of cervical cancers in females.
|
|
How many HPV vaccines are licensed?
|
Two HPV vaccines are licensed: a quadrivalent vaccine (HPV4) for the prevention of cervical, vaginal and vulvar cancers (in females) and genital warts (in females and males), and a bivalent vaccine (HPV2) for the prevention of cervical cancers in females.
|
|
HPV vaccines are most effective for both males and females when given?
|
before exposure to HPV through sexual contact.
|
|
• HPV4 or HPV2 is recommended for ?
|
the prevention of cervical precancers and cancers in females.
|
|
• HPV4 is recommended for the prevention of ?
|
cervical, vaginal and vulvar precancers and cancers and genital warts in females.
|
|
• Administer the first dose of HPV vaccine to females at age?
|
11 or 12 years.
|
|
• Administer the HPV series to females at age?
|
13 through 18 years if not previously vaccinated.
|
|
• HPV4 may be administered in a 3-dose series to males aged?
|
9 through 18 years to reduce their likelihood of acquiring genital warts.
|
|
Meningococcal conjugate vaccine?
|
(MCV4) Meningococcal conjugate vaccine
|
|
Administer MCV 4 at age?
|
11 or 12 years, or at age 13 through 18 years if not previously vaccinated.
|
|
Administer MCV 4 to?
|
previously unvaccinated college freshmen living in a dormitory.
|
|
Administer MCV 4 to children aged?
|
2 through 10 years with persistent complement component deficiency, anatomic or functional asplenia, or certain other conditions placing them at high risk.
|
|
Administer MCV 4to children previously vaccinated with?
|
MCV4 or MPSV4 who remain at increased risk after 3 years (if first dose administered at age 2 through 6 years) or after 5 years (if first dose administered at age 7 years or older). Persons whose only risk factor is living in on-campus housing are not recommended to receive an additional dose. See MMWR 2009
|
|
Administer Influenza vaccine when? to whom?
|
(seasonal).
|
|
For healthy nonpregnant persons aged 7 through 18 years (i.e., those who do not have underlying medical conditions that predispose them to influenza complications), which flu vaccine may be administered?
|
LAIV or TIV may be used.
|
|
Administer 2 doses (separated by at least 4 weeks) to children aged ?
|
younger than 9 years who are receiving influenza vaccine for the first time or who were vaccinated for the first time during the previous influenza season but only received 1 dose.
|
|
• For recommendations for use of influenza A (H1N1) 2009 monovalent vaccine. See MMWR 2009
|
58(No. RR-10).
|
|
Pneumococcal polysaccharide vaccine?
|
PPSV.
|
|
Administer PPSV to?
|
children with certain underlying medical conditions, including a cochlear implant.
|
|
When should a single revaccination should be administered?
|
after 5 years to children with functional or anatomic asplenia or an immunocompromising condition. See MMWR 1997
|
|
at least ___ apart?
|
Administer 2 doses of Hepatitis A vaccine (HepA). at least 6 months apart.
|
|
HepA is recommended for children aged older than ?
|
23 months who live in areas where vaccination programs target older children, who are at increased risk for infection, or for whom immunity against hepatitis A is desired.
|
|
Administer the 3-dose Hepatitis B vaccine (HepB) series to?
|
those not previously vaccinated.
|
|
For children aged 11 through 15 years, a 2-dose series (separated by at least 4 months) of adult formulation called ___ is licensed?
|
Recombivax HB is licensed
|
|
Inactivated poliovirus vaccine?
|
(IPV)
|
|
The final dose in the IPV series should be administered on or after the?
|
fourth birthday and at least 6 months following the previous dose.
|
|
If both OPV and IPV were administered as part of a series, a total of ____ doses should be administered, regardless of the child’s current age?
|
If both OPV and IPV were administered as part of a series, a total of 4 doses should be administered, regardless of the child’s current age.
|
|
MMR?
|
Measles, mumps, and rubella vaccine (MMR).
|
|
If not previously vaccinated, with MMR, administer?
|
2 doses or the second dose for those who have received only 1 dose, with at least 28 days between doses.
|
|
Varicella vaccine for persons aged ___ through ___ years without evidence of immunity?
|
Varicella vaccine for persons aged 7 through 18 years without evidence of immunity (see MMWR 2007
|
|
For persons aged ___through ___ years, the minimum interval between varicella doses is 3 months. However, if the second dose was administered at least 28 days after the first dose, it can be accepted as valid?
|
For persons aged 7 through 12 years, the minimum interval between varicella doses is 3 months. However, if the second dose was administered at least 28 days after the first dose, it can be accepted as valid.
|
|
For persons aged 13 years and older, the minimum interval between varicella doses is 28 days?
|
For persons aged 13 years and older, the minimum interval between varicella doses is 28 days.
|
|
Administer the 2nd dose of HPV?
|
1-2 months after the first dose an the third dose 6 months after the first dose (at least 24 weeks after the first dose.)
|